Alkermes plc.
ALKS
60 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 4 9:00 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $43.05 | $87.6K | 229,524(D) | View → |
| Jun 4, 2026 | Jun 4 8:16 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $43.05 | $87.6K | — | View → |
| Jun 1, 2026 | Jun 1 11:26 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $41.67 | $375.0K | 77,389(D) | View → |
| Jun 1, 2026 | Jun 1 8:29 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $41.67 | $375.0K | — | View → |
| May 29, 2026 | May 29 10:03 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sale | 16,217 | $42.36 | $687.0K | 7,717(D) | View → |
| May 4, 2026 | May 5 12:42 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $33.20 | $67.5K | 231,558(D) | View → |
| May 4, 2026 | May 4 8:30 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $33.20 | $67.5K | — | View → |
| May 1, 2026 | May 2 1:05 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $33.40 | $300.6K | 81,389(D) | View → |
| May 1, 2026 | May 1 8:22 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $33.40 | $300.6K | — | View → |
| Apr 6, 2026 | Apr 6 11:56 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $34.57 | $70.3K | 233,592(D) | View → |
| Apr 6, 2026 | Apr 6 8:16 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $34.57 | $70.3K | — | View → |
| Apr 1, 2026 | Apr 1 10:58 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $35.51 | $319.6K | 85,389(D) | View → |
| Apr 1, 2026 | Apr 1 8:13 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $35.51 | $319.6K | — | View → |
| Mar 2, 2026 | Mar 5 1:19 AM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sale | 6,890 | $29.29 | $201.8K | 7,717(D) | View → |
| Mar 2, 2026 | Mar 5 1:18 AM | Christian Todd NicholsSVP, Chief Commercial Officer | Sale | 6,000 | $30.00 | $180.0K | 109,769(D) | View → |
| Mar 2, 2026 | Mar 5 1:16 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $29.72 | $267.5K | 89,389(D) | View → |
| Mar 3, 2026 | Mar 5 1:15 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $29.76 | $60.5K | 235,626(D) | View → |
| Mar 2, 2026 | Mar 5 1:15 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $29.29 | $59.6K | 237,660(D) | View → |
| Mar 3, 2026 | Mar 3 10:12 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $29.76 | $60.5K | — | View → |
| Mar 2, 2026 | Mar 2 10:15 PM | Nichols Christian Todd | Proposed Sale | 6,000 | $30.00 | $180.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 9 10:18 PM | Joshua ReedSVP, Chief Financial Officer | Option Exercise | 9,164 | — | 27,492(D) | View → |
| Oct 7, 2026 | Oct 9 10:16 PM | Anne Clem WhitakerDirector | Grant/Award | 25,237 | $41.45 | 17,998(D) | View → |
| Sep 1, 2026 | Sep 1 11:08 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $24.59 | 61,276(D) | View → |
| Aug 5, 2026 | Aug 8 1:17 AM | Blair Curtis JacksonDirector, President & CEO, Alkermes plc | Grant/Award | 217,534 | $49.61 | 124,305(D) | View → |
| Aug 3, 2026 | Aug 3 11:16 PM | Nancy Lynn Snyderman MDDirector | Option Exercise | 44,472 | $46.72 | 0(D) | View → |
| Aug 3, 2026 | Aug 3 11:12 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $24.59 | 66,276(D) | View → |
| Jul 1, 2026 | Jul 1 10:29 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 1,356(D) | View → |
| Jun 1, 2026 | Jun 1 11:26 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 6,356(D) | View → |
| May 29, 2026 | May 29 10:03 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 16,217 | $20.03 | 12,826(D) | View → |
| May 21, 2026 | May 23 12:08 AM | Christopher I WrightDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 23 12:08 AM | Christopher I WrightDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 23 12:06 AM | Frank Anders WilsonDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 23 12:06 AM | Frank Anders WilsonDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 23 12:04 AM | Nancy Lynn Snyderman MDDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 23 12:04 AM | Nancy Lynn Snyderman MDDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 23 12:03 AM | Brian P MckeonDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 23 12:03 AM | Brian P MckeonDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 23 12:01 AM | Nancy LurkerDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 23 12:01 AM | Nancy LurkerDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 23 12:00 AM | Cato T LaurencinDirector | Option Exercise | 6,142 | — | 0(D) | View → |
Page 1 of 3
Next →